vs

Side-by-side financial comparison of Merchants Bancorp (MBIN) and REPLIGEN CORP (RGEN). Click either name above to swap in a different company.

REPLIGEN CORP is the larger business by last-quarter revenue ($197.9M vs $175.2M, roughly 1.1× Merchants Bancorp). Merchants Bancorp runs the higher net margin — 38.6% vs 6.7%, a 31.9% gap on every dollar of revenue. Over the past eight quarters, REPLIGEN CORP's revenue compounded faster (14.4% CAGR vs 4.8%).

Ameris Bancorp is an American bank holding company headquartered in Atlanta, Georgia. Through its bank subsidiary, Ameris Bank, the company operates full-service branches in Georgia, Alabama, Florida, North Carolina and South Carolina, and mortgage-only locations in Georgia, Alabama, Florida, North Carolina, South Carolina, Virginia, Maryland, and Tennessee. The company offers online and mobile banking options for both consumers and businesses.

Repligen Corporation is a global life sciences company devoted to the development and commercialization of innovative bioprocessing technologies and systems that enable efficiencies in the process of manufacturing biological drugs.2025 The company is based in Waltham, Massachusetts,2014 and was incorporated in Delaware in 1981. A public company, Repligen is listed on the NASDAQ exchange under the symbol RGEN. As of 2025, Repligen employs over 1,900 employees globally and serves primarily biop...

MBIN vs RGEN — Head-to-Head

Bigger by revenue
RGEN
RGEN
1.1× larger
RGEN
$197.9M
$175.2M
MBIN
Higher net margin
MBIN
MBIN
31.9% more per $
MBIN
38.6%
6.7%
RGEN
Faster 2-yr revenue CAGR
RGEN
RGEN
Annualised
RGEN
14.4%
4.8%
MBIN

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
MBIN
MBIN
RGEN
RGEN
Revenue
$175.2M
$197.9M
Net Profit
$67.7M
$13.3M
Gross Margin
52.5%
Operating Margin
9.0%
Net Margin
38.6%
6.7%
Revenue YoY
13.6%
Net Profit YoY
16.3%
143.9%
EPS (diluted)
$1.25
$0.24

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MBIN
MBIN
RGEN
RGEN
Q1 26
$175.2M
Q4 25
$185.3M
$197.9M
Q3 25
$171.1M
$188.8M
Q2 25
$179.2M
$182.4M
Q1 25
$145.9M
$169.2M
Q4 24
$193.8M
$174.1M
Q3 24
$149.6M
$154.9M
Q2 24
$159.5M
$154.1M
Net Profit
MBIN
MBIN
RGEN
RGEN
Q1 26
$67.7M
Q4 25
$13.3M
Q3 25
$54.7M
$14.9M
Q2 25
$38.0M
$14.9M
Q1 25
$58.2M
$5.8M
Q4 24
$-30.3M
Q3 24
$61.3M
$-654.0K
Q2 24
$76.4M
$3.3M
Gross Margin
MBIN
MBIN
RGEN
RGEN
Q1 26
Q4 25
52.5%
Q3 25
53.2%
Q2 25
50.0%
Q1 25
53.6%
Q4 24
26.1%
Q3 24
50.0%
Q2 24
49.8%
Operating Margin
MBIN
MBIN
RGEN
RGEN
Q1 26
Q4 25
39.9%
9.0%
Q3 25
37.8%
8.9%
Q2 25
27.3%
7.6%
Q1 25
52.4%
3.9%
Q4 24
66.0%
-17.7%
Q3 24
54.4%
-5.1%
Q2 24
62.2%
1.0%
Net Margin
MBIN
MBIN
RGEN
RGEN
Q1 26
38.6%
Q4 25
6.7%
Q3 25
32.0%
7.9%
Q2 25
21.2%
8.2%
Q1 25
39.9%
3.4%
Q4 24
-17.4%
Q3 24
41.0%
-0.4%
Q2 24
47.9%
2.2%
EPS (diluted)
MBIN
MBIN
RGEN
RGEN
Q1 26
$1.25
Q4 25
$1.28
$0.24
Q3 25
$0.97
$0.26
Q2 25
$0.60
$0.26
Q1 25
$0.93
$0.10
Q4 24
$1.84
$-0.55
Q3 24
$1.17
$-0.01
Q2 24
$1.49
$0.06

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MBIN
MBIN
RGEN
RGEN
Cash + ST InvestmentsLiquidity on hand
$83.2M
$767.6M
Total DebtLower is stronger
$32.0M
$542.2M
Stockholders' EquityBook value
$2.3B
$2.1B
Total Assets
$20.3B
$2.9B
Debt / EquityLower = less leverage
0.01×
0.26×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MBIN
MBIN
RGEN
RGEN
Q1 26
$83.2M
Q4 25
$767.6M
Q3 25
$748.7M
Q2 25
$708.9M
Q1 25
$697.2M
Q4 24
$757.4M
Q3 24
$784.0M
Q2 24
$809.1M
Total Debt
MBIN
MBIN
RGEN
RGEN
Q1 26
$32.0M
Q4 25
$542.2M
Q3 25
$537.9M
Q2 25
Q1 25
Q4 24
$525.6M
Q3 24
Q2 24
Stockholders' Equity
MBIN
MBIN
RGEN
RGEN
Q1 26
$2.3B
Q4 25
$2.3B
$2.1B
Q3 25
$2.2B
$2.1B
Q2 25
$2.2B
$2.1B
Q1 25
$2.2B
$2.0B
Q4 24
$2.2B
$2.0B
Q3 24
$1.9B
$2.0B
Q2 24
$1.9B
$2.0B
Total Assets
MBIN
MBIN
RGEN
RGEN
Q1 26
$20.3B
Q4 25
$19.4B
$2.9B
Q3 25
$19.4B
$2.9B
Q2 25
$19.1B
$2.9B
Q1 25
$18.8B
$2.9B
Q4 24
$18.8B
$2.8B
Q3 24
$18.7B
$2.8B
Q2 24
$18.2B
$2.9B
Debt / Equity
MBIN
MBIN
RGEN
RGEN
Q1 26
0.01×
Q4 25
0.26×
Q3 25
0.26×
Q2 25
Q1 25
Q4 24
0.27×
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MBIN
MBIN
RGEN
RGEN
Operating Cash FlowLast quarter
$25.7M
Free Cash FlowOCF − Capex
$17.6M
FCF MarginFCF / Revenue
8.9%
Capex IntensityCapex / Revenue
4.1%
Cash ConversionOCF / Net Profit
1.93×
TTM Free Cash FlowTrailing 4 quarters
$93.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MBIN
MBIN
RGEN
RGEN
Q1 26
Q4 25
$-341.2M
$25.7M
Q3 25
$29.8M
$48.1M
Q2 25
$-121.2M
$28.6M
Q1 25
$148.0M
$15.0M
Q4 24
$-835.3M
$39.2M
Q3 24
$-492.6M
$49.3M
Q2 24
$51.1M
$42.2M
Free Cash Flow
MBIN
MBIN
RGEN
RGEN
Q1 26
Q4 25
$-362.2M
$17.6M
Q3 25
$24.0M
$43.4M
Q2 25
$-125.7M
$21.5M
Q1 25
$141.2M
$11.4M
Q4 24
$-853.7M
$33.6M
Q3 24
$-497.2M
$42.3M
Q2 24
$45.8M
$37.4M
FCF Margin
MBIN
MBIN
RGEN
RGEN
Q1 26
Q4 25
-195.5%
8.9%
Q3 25
14.0%
23.0%
Q2 25
-70.1%
11.8%
Q1 25
96.8%
6.8%
Q4 24
-440.6%
19.3%
Q3 24
-332.4%
27.3%
Q2 24
28.7%
24.3%
Capex Intensity
MBIN
MBIN
RGEN
RGEN
Q1 26
Q4 25
11.3%
4.1%
Q3 25
3.4%
2.5%
Q2 25
2.5%
3.9%
Q1 25
4.7%
2.1%
Q4 24
9.5%
3.2%
Q3 24
3.0%
4.5%
Q2 24
3.3%
3.1%
Cash Conversion
MBIN
MBIN
RGEN
RGEN
Q1 26
Q4 25
1.93×
Q3 25
0.54×
3.23×
Q2 25
-3.19×
1.92×
Q1 25
2.54×
2.57×
Q4 24
Q3 24
-8.04×
Q2 24
0.67×
12.70×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MBIN
MBIN

Net Interest Income$128.6M73%
Noninterest Income$46.6M27%

RGEN
RGEN

Segment breakdown not available.

Related Comparisons